PRODUCT FOR INHIBITION OF ATTACHMENT OF H. INFLUENZAE TO HUMAN CELLS.

摘要

A product is provided for inhibiting the attachment of H. influenzae to human cells, such as pharyngeal cells, by contacting the bacilli with phosphorylated recombinant human 'beta'-casein that have at least 3 phosphate groups. The product containing phosphorylated recombinant human 'beta'-casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otitis media in infants. The phosphorylated recombinant human 'beta'-casein may also be administered as a throat spray or used in nose drops or a spray.